GW Pharmaceuticals plc (AIM:GWP) today announces that Sativex® oromucosal spray
has been approved in the Czech Republic as a treatment for spasticity due to
Multiple Sclerosis (MS).
This approval follows GW's announcement on 22nd March 2011 that the European
Mutual Recognition Procedure had
perhaps I should move?
John
United States of I can't get it in America
--- On Fri, 4/15/11, fr...@franksheldon.com fr...@franksheldon.com wrote:
From: fr...@franksheldon.com fr...@franksheldon.com
Subject: [TMIC] Sativex
To: tmic-list@eskimo.com
Date: Friday, April 15, 2011, 8:12 AM
GW
Keep us informed – and thanks!
Janice
From: fr...@franksheldon.com
Sent: Friday, April 15, 2011 7:12 AM
To: tmic-list@eskimo.com
Subject: [TMIC] Sativex
GW Pharmaceuticals plc (AIM:GWP) today announces that Sativex® oromucosal spray
has been approved in the Czech Republic as a treatment for
Hi everybody,
Please check the Vanity Fair article of JANUARY 11, and read the Deadly
Medication piece. It is scary and we should all be aware that the
pharmaceuticals' clinical trials are a joke. And that the FDA doesn't seem to
care. We are constantly exchanging our experiences with a
